OSI-930 is a selective thiophene-derived tyrosine kinase inhibitor with potential antineoplastic activity. Tyrosine kinase inhibitor OSI-930 inhibits stem cell factor receptor (c-Kit) and the vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of both tumor cell proliferation and tumor angiogenesis. Both c-Kit and VEGFR2 are overexpressed in a variety of cancers. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).

 

Brand: BCM

 

Boiling Point: 517.4±50.0 °C(Predicted)

 

pKa: 11.36±0.70(Predicted)

 

Solubility: Soluble in DMSO. Insoluble in Water.

 

InChi Key: FGTCROZDHDSNIO-UHFFFAOYSA-N

 

Attribute
[Chem Name]	3-((Quinolin-4-ylmethyl)amino)-N-(4-(trifluoromethoxy)phenyl)thiophene-2-carboxamide
[Synonym]	OSI-930
[CAS No.]	728033-96-3
[MDL No.]	MFCD11100358
[Formula]	C22H16F3N3O2S
[Molecular]	443.44
[Form]	Solid
[Storage]	Keep in dark place. Inert atmosphere,2-8°C

Goods Tag